A

Screening for Clostridioides difficile colonization at admission to the hospital: a multi-centre study

Clinical Microbiology and Infection, vol. 29, pp. 891–896

Abstract

OBJECTIVES: To assess the value of screening for Clostridioides difficile colonization (CDC) at hospital admission in an endemic setting. METHODS: A multi-centre study was conducted at four hospitals located across the Netherlands. Newly admitted patients were screened for CDC. The risk of development of Clostridioides difficile infection (CDI) during admission and 1-year follow-up was assessed in patients with and without colonization. C. difficile isolates from patients with colonization were compared with isolates from incident CDI cases using core genome multi-locus sequence typing to determine whether onwards transmission had occurred. RESULTS: CDC was present in 108 of 2211 admissions (4.9%), whereas colonization with a toxigenic strain (toxigenic Clostridoides difficile colonization [tCDC]) was present in 68 of 2211 admissions (3.1%). Among these 108 patients with colonization, diverse PCR ribotypes were found and no 'hypervirulent' PCR ribotype 027 (RT027) was detected (95% CI, 0-0.028). None of the patients with colonization developed CDI during admission (0/49; 95% CI, 0-0.073) or 1-year follow-up (0/38; 95% CI, 0-0.93). Core genome multi-locus sequence typing identified six clusters with genetically related isolates from patients with tCDC and CDI; however, in these clusters, only one possible transmission event from a patient with tCDC to a patient with CDI was identified based on epidemiological data. CONCLUSION: In this endemic setting with a low prevalence of 'hypervirulent' strains, screening for CDC at admission did not detect any patients with CDC who progressed to symptomatic CDI and detected only one possible transmission event from a patient with colonization to a patient with CDI. Thus, screening for CDC at admission is not useful in this setting.

Authors 12

  1. Leiden University Medical Center

    Affiliation as printed

    Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: m.j.t.crobach@lumc.nl

    Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands

  2. Leiden University Medical Center

    Affiliation as printed

    Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands

  3. Amphia Ziekenhuis

    Affiliation as printed

    Department of Medical Microbiology, Amphia Hospital Breda, the Netherlands

  4. Erasmus MC

    Affiliation as printed

    Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, the Netherlands

  5. Radboud University Medical Center

    Affiliation as printed

    Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands

  6. Wellcome Sanger Institute

    Affiliation as printed

    Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, United Kingdom

  7. Leiden University Medical Center

    Affiliation as printed

    Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands

  8. Leiden University Medical Center

    Affiliation as printed

    Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands

  9. Leiden University Medical Center

    Affiliation as printed

    Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands

  10. Wellcome Sanger Institute

    Affiliation as printed

    Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, United Kingdom

  11. Wellcome Sanger Institute

    Affiliation as printed

    Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, United Kingdom

  12. Leiden University Medical Center · National Institute for Public Health and the Environment

    Affiliation as printed

    Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands

    Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands

    Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands

Cited by 9 stored of 9

9 results

No patents citing this paper on Lens.org (checked 2026-10-11).

References 24